Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06950593 · ClinicalTrials.gov registry record · NA
Transcutaneous Electrical Stimulation for Stroke Patients
A NA study of Upper Limb Hemiparesis Following Stroke, sponsored by Shirley Ryan AbilityLab.
- Recruiting
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT06950593: Recruiting NA study of Upper Limb Hemiparesis Following Stroke, sponsored by Shirley Ryan AbilityLab.
NCT06950593 is a NA study of Upper Limb Hemiparesis Following Stroke that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06950593, a NA study of Upper Limb Hemiparesis Following Stroke, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.
- RECRUITING
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the feasibility and impact of transcutaneous electrical stimulation of the spinal cord (TESS) on the recovery of post-stroke individuals who have upper limb hemiparesis. It will compare outcomes measures between individuals who receive upper limb task specific training with TESS and individuals who receive task specific training of the upper limb with Sham, or fake, TESS.
Primary Outcome
The FMUE is an impairment scale that addresses both synergy and isolated movements of the upper limb. The subscales include reflex movements, flexor synergy, extensor synergy, movements out of synergy, combining synergies, wrist, hand, and coordination subscales. The total score ranges from 0 to 66 with higher scores indicating greater function.
Conditions Studied
Interventions
- OTHER Task Specific Training (TST)
- OTHER Transcutaneous electrical spinal cord stimulation (TESS)
- OTHER Sham transcutaneous electrical spinal cord stimulation (Sham TESS)
Study Locations (1)
Illinois
- Shirley Ryan AbilityLab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2025-08-18 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What NCT06950593 shows while recruiting
NCT06950593 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Upper Limb Hemiparesis Following Stroke appearing as the primary indexed condition, and to 3 interventions - of which Task Specific Training (TST) is the first listed.
NCT06950593 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06950593 about?
NCT06950593 is a clinical study titled "Transcutaneous Electrical Stimulation for Stroke Patients". This study aims to evaluate the feasibility and impact of transcutaneous electrical stimulation of the spinal cord (TESS) on the recovery of post-stroke individuals who have upper limb hemiparesis. It will compare outcomes measures between individuals who receive upper limb task specific training wi...
What is the current status of trial NCT06950593?
This trial is currently recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2025-08-18. Estimated completion is 2027-01-01.
What conditions does trial NCT06950593 study?
This clinical trial studies the following conditions: Upper Limb Hemiparesis Following Stroke.
What interventions are being tested in trial NCT06950593?
The interventions under investigation include: Task Specific Training (TST) (OTHER), Transcutaneous electrical spinal cord stimulation (TESS) (OTHER), Sham transcutaneous electrical spinal cord stimulation (Sham TESS) (OTHER).
Who is sponsoring clinical trial NCT06950593?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06950593 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06950593's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy